Late Breaking Clinical Trials Session

15 Apr 2024 03:00 pm 04:00 pm

Hall A

AlessiaFornoni Chairperson United States

MichelleRheault Chairperson University of MinnesotaUnited States

Add to My Schedule

Time	Session

03:00 pm 03:10 pm	Predicting the Risks of Kidney Failure and Death in Adults With Moderate-to-severe Chronic Kidney Disease (KDpredict) PietroRavani Free Communication pravani@ucalgary.caUniversity of CalgaryCanada
03:10 pm 03:25 pm	Plasma Exchange in ANCA Associated Vasculitis GN: Update After Pexivas – Recommendations and Updates Wladimir MietekSzpirt Speaker wladimir.mietek.szpirt.01@regionh.dkRigshospitalet, University of Copenhagen, Dept. of Nephrology, Denmark, Senior Research ConsultantDenmark
03:25 pm 03:35 pm	EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY: INTERIM RESULTS FROM THE PHASE 3 APPLAUSE-IgAN STUDY DanaRizk Free Communication drizk@uabmc.eduUniversity of Alabama at BirminghamUnited States
03:35 pm 03:45 pm	SPARSENTAN VS IRBESARTAN IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN): SUBGROUP ANALYSES OF 2-YEAR RESULTS FROM THE PIVOTAL PHASE 3 PROTECT TRIAL JonathanBarratt Free Communication jb81@leicester.ac.ukUniversity of Leicester, Leicester, UKUnited Kingdom
03:45 pm 03:55 pm	PREGNANCY AMONG WOMEN ON CHRONIC DIALYSIS : THE FRENCH COHORT CécileCouchoud Free Communication cecile.couchoud@biomedecine.frREIN registry, Agence de la biomédecine, FranceFrance